Vical Biotech and NIH jointly develops HIV vaccine

by Medindia Content Team on  October 12, 2005 at 5:54 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

Vical Biotech and NIH jointly develops HIV vaccine
A new HIV vaccine is being jointly developed by Vical Pharmaceuticals and the National Institute of Health (NIH). The new HIV vaccine was developed by the scientistis in NIH and the Federal government is using the Vical Biotechs DNA delivery technology to inserting the HIV genes.

Vical Inc. is a Biotechnology company based in California, which has developed an accurate DNA delivery system, last month Vical has agreed to grant Merck to use its gene delivery system technology for cancer vaccines in exchange for rights to use the technology for vaccines against HIV. The Phase 2 clinical trial is performed by HIV vaccine trial group of NIH, this technology incorporates 4 HIV genes and the NIH trial group evaluates and compares different HIV/AIDS vaccines.

The news sent shares of Vical up $1.16, or 21.60 percent, to $6.54 in morning trade on Nasdaq, after touching high of $6.98. The stock was among the biggest percentage gainers on Nasdaq.

Source: Reuters.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Oral Health And AIDS AIDS/HIV AIDS/HIV - Epidemiology AIDS/HIV - Clinical Features AIDS/HIV - Health Education AIDS/HIV - Prevention And Transmission AIDS / HIV - Treatment AIDS/HIV- Lab Tests and Faqs Prostitution: Fresh Stakes in the Oldest Trade AIDS and Pregnancy 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive